Investor Information

News

Summit Therapeutics Reports Operational Progress and Financial Results for the Third Quarter and Nine Months Ended September 30, 2024

View News

Summit Therapeutics to Host Third Quarter 2024 Financial Results & Operational Progress Call on October 30, 2024

View News

More Information

Share Price

NASDAQ: SMMT

18.99 USD

01-Nov-2024 16:00 UTC-4

More Information

SEC Filings

Quarterly report pursuant to sections 13 or 15(d)

View News

Current report filing

View News

More Information

Email Alerts